Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
Completed
- Conditions
- GERD
- Registration Number
- NCT00524355
- Lead Sponsor
- AstraZeneca
- Brief Summary
To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2717
Inclusion Criteria
- Patients from both sexes, aged 18 years or older
- Patients complaining of symptoms consistent with reflux disease
Read More
Exclusion Criteria
- Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇻🇳Ho Chi Minh City, Vietnam